Schedule 13D ownership disclosure

Tyra Biosciences Inc

Security class unavailable · CUSIP: 90240B106

Event date: 2021-09-17

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
4,080,296
Percent of class
9.6000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-21-119793
Form type
SC 13D
Filer
Alta Partners NextGen Fund II Management, LLC
CIK
CIK 1881002
Filed
Sep 27, 2021
Reporting period
Sep 17, 2021
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub